A Brief Study about Menopause and Gynaecological Malignancy

Authors

  • Sabera Khatun Department of Gynaecological Oncology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.
  • Jannatul Ferdous Department of Gynaecological Oncology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.

DOI:

https://doi.org/10.9734/bpi/cpms/v7/7125F

Keywords:

Menopause, malignancy, cervix, ovary, endometrium

Abstract

Premature menopause can occur as a result of cancer treatment. Cervical cancer is the most common gynaecological cancer. Persistent HPV infection is more common in postmenopausal women. In postmenopausal women, HPV vaccination has no role in primary cervical cancer prevention. Cervical cancer symptoms in postmenopausal women are unfortunately non-specific and related with co-morbidities. As a result, each sign of cervical cancer in a postmenopausal woman should be investigated thoroughly. Among all gynecologic cancers, ovarian cancer is the leading cause of death. The majority of postmenopausal women with ovarian cancer present with ambiguous symptoms and are in an advanced stage of the disease at the time of presentation. In the United States, endometrial cancer is the most frequent gynecologic malignancy. The majority of endometrial carcinomas are detected early and have a favourable prognosis. Though vulvar and vaginal cancers are uncommon, they are common in postmenopausal women. Any postmenopausal woman who has been itching for a long time, has a pervaginal discharge, or has a vulva or vaginal ulcer should be evaluated thoroughly. So main objective of this writing is to aware the gynaecological oncologists about the special aspects of gynaecological cancers in menopausal woman.

Published

2022-07-25

How to Cite

Sabera Khatun, & Jannatul Ferdous. (2022). A Brief Study about Menopause and Gynaecological Malignancy. Current Practice in Medical Science Vol. 7, 1–11. https://doi.org/10.9734/bpi/cpms/v7/7125F